GLOBUS MEDICAL INC

$78.93$3.28 (+4.34%)
Last updated on --.

GLOBUS MEDICAL INC price

24 Hours+4.34%+$3.280
30 days+6.25%+$4.640
60 days-12.96%-$11.26
90 days+4.65%+$3.510

About GLOBUS MEDICAL INC

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Stock ticker
GMED
Company
Globus Medical, Inc.
Industry
Healthcare
Category
US
Stock split / reverse split
--
Launch date
Aug 3, 2012
Listed exchange
NYSE

Financials

Q2 FY2026 Earnings
Report period: Apr 1, 2026 – Jun 30, 2026

Summary: GMED reported Revenue of 789.61M (+5.94%), beating expectations; EPS of 1.34 (+55.81%), beating expectations.

Revenue (USD)Beat789.61M+5.93%782.88M+5.40%6.73M+0.85%
EPS (USD)Beat1.34+55.81%1.10+44.73%0.24+21.81%
Financial estimates
● Actual● Estimate
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
1.490.881.010.901.10
+547.82%+131.57%+431.57%+66.66%-26.18%
● EPS● YoY
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
4.96B5.10B5.30B5.44B5.49B
665.41M696.82M729.51M707.24M719.66M
13.41%13.67%13.75%13.00%13.11%
● Assets● Liabilities● Ratio
Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
77.87M249.70M248.59M202.36M209.74M
+43.50%+22.60%+18.18%+14.13%+169.36%
● CFO● YoY

Shareholders

Shareholders
BLACKROCK, INC.7.98%
JUPITER TOPCO LLC6.05%
VANGUARD CAPITAL MANAGEMENT LLC3.77%
VANGUARD PORTFOLIO MANAGEMENT LLC3.68%
INVESCO LTD.3.18%
Others75.31%
Institutions
% Owned88.80%+7.78%
Shares held120.21M+10.72M
Institutions615-7
% OwnedPrice
Name% OwnedChange
BLACKROCK, INC.7.98%+309.31K
JUPITER TOPCO LLC6.05%+8.20M
VANGUARD CAPITAL MANAGEMENT LLC3.77%+74.80K
VANGUARD PORTFOLIO MANAGEMENT LLC3.68%+114.93K
INVESCO LTD.3.18%-6.88K

GLOBUS MEDICAL INC conversion tables

GMEDGMED
USDUSD
0.5 GMED39.46 USD
1 GMED78.93 USD
5 GMED394.65 USD
10 GMED789.3 USD
USDUSD
GMEDGMED
0.5 USD0.0063347 GMED
1 USD0.012669 GMED
5 USD0.063347 GMED
10 USD0.12669 GMED

More to explore

FAQ

GMED is trading at $78.93, +4.34% over the last 24 hours. Track live moves on the price chart at the top of this page.

The GMED stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. GMED is currently trading at $78.93, +4.34% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on GMED price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the Healthcare sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.

P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. GMED's P/E ratio is currently 20.13 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from GMED; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against GMED's historical range and other companies in the Healthcare sector.

Globus Medical, Inc.'s market cap is currently 10.51B USD. Market cap is calculated as stock price × total shares outstanding.

Disclaimer

The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.

OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.